|
|
Office Locations:
|
1370 Avenue of the Americas, 33rd Floor
New York, NY 10019
Phone: 212-660-8060
Fax: 212-660-8098
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Consonance Capital Partners (CCP) is a private equity manager focused exclusively on investing in the U.S. healthcare industry. CCP's founders, Mitchell Blutt, MD, Benjamin Edmands, Stephen McKenna, and Nancy-Ann DeParle, partnered together for over a decade while at JPMorgan Partners and its successor and predecessor entities, and have over 65 years of combined experience in private equity investing, primarily within healthcare. Consonance Capital Partners benefits from its association with Consonance Capital Management, a healthcare-focused manager founded in 2005 whose activity is investing in public equities. CCP targets growth equity, leveraged buyouts, and recapitalization transactions in the lower middle market. Target companies generally have between $25 million and $500 million in revenues. July 2014, Consonance announced the final closing of its $500 million healthcare private equity fund. The fund was oversubscribed, surpassing its $350 million target and reaching its fundraising cap of $500 million.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
